These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9123000)

  • 21. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage.
    Kinukawa T; Ono Y; Takeuchi N; Hattori R; Ohshima S
    Transplant Proc; 1997; 29(1-2):946-7. PubMed ID: 9123600
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic approach with patient-specific cyclosporine administration protocol in renal transplantation.
    Sernyak PS; Chernobrivtsev PA; Kalinin DI; Lunyova AG; Denisov VK
    Transplant Proc; 1997; 29(1-2):296. PubMed ID: 9123003
    [No Abstract]   [Full Text] [Related]  

  • 26. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
    Carvalho MF; Adoni T; Saggioro FP; Soares V
    Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607
    [No Abstract]   [Full Text] [Related]  

  • 28. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 29. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract]   [Full Text] [Related]  

  • 30. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation.
    Kaden J; May G; Strobelt V; Groth J; Müller P
    Transplant Proc; 1997; 29(1-2):344-7. PubMed ID: 9123032
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic rejection in cyclosporin A treated renal allograft recipients with allopeptide reactive T cells.
    Iniotaki-Theodoraki A; Boletis J; Stamatiadis D; Choremi H; Kostakis A
    Transplant Proc; 1999; 31(1-2):1168-70. PubMed ID: 10083522
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
    Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
    Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 36. High dose steroid regime: a tool for reducing organ rejection.
    Jawad F; Naqvi A; Rizvi A
    Transplant Proc; 2001 Aug; 33(5):2786. PubMed ID: 11498160
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
    Opelz G
    Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized study with cyclosporine in kidney transplantation: 10-year follow-up.
    Ponticelli C; Civati G; Tarantino A; Quarto di Palo F; Corbetta G; Minetti L; Vegeto A; Belli L
    J Am Soc Nephrol; 1996 May; 7(5):792-7. PubMed ID: 8738816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression.
    Boletis JN; Theodoropoulou H; Hiras T; Stamatiadis D; Darema M; Psimenou E; Stathakis C; Kostakis A
    Transplant Proc; 2001; 33(7-8):3184-6. PubMed ID: 11750366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.